Results 241 to 250 of about 1,710,685 (294)
Some of the next articles are maybe not open access.

Drug Approval and Surveillance

International Journal of Gynecology & Obstetrics, 1980
ABSTRACTThe author proposes that current regulations governing the licensing of drugs, particularly in the United States, need to be changed and replaced by a system of provisional or conditional licensing and increased postmarketing surveillance of drug use.
openaire   +2 more sources

Tardive Dyskinesia Drug Approved

JAMA, 2017
The first drug for adults with tardive dyskinesia (TD) has received FDA approval. Tardive dyskinesia is a neurological disorder that causes repetitive, involuntary movements such as abnormal tongue and lip movements, cheek bulging, foot tapping, shoulder shrugging, and rocking and swaying movements.
openaire   +2 more sources

Drug Approvals

The Nurse Practitioner, 2007
Gary, Laustsen   +2 more
openaire   +3 more sources

2009 FDA drug approvals

Nature Reviews Drug Discovery, 2010
In a year in which regulators and drug companies gained familiarity with risk management strategies, the number of new drug approvals was similar to that in 2008.
openaire   +2 more sources

2014 FDA drug approvals

Nature Reviews Drug Discovery, 2015
The FDA approved 41 new therapeutics in 2014, but the bumper year fell short of the commercial power of the drugs approved in 2013.
openaire   +2 more sources

2016 FDA drug approvals

Nature Reviews Drug Discovery, 2017
FDA approval count fell last year, despite a steady regulatory filing rate. FDA approval count fell last year, despite a steady regulatory filing rate.
openaire   +2 more sources

2017 FDA drug approvals

Nature Reviews Drug Discovery, 2018
This corrects the article DOI: 10.1038/nrd.2018.4.
openaire   +3 more sources

Drug approvals

The Nurse Practitioner, 2010
openaire   +3 more sources

Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies

Ca-A Cancer Journal for Clinicians, 2022
Paolo Tarantino   +2 more
exaly  

Targeted drug delivery strategies for precision medicines

Nature Reviews Materials, 2021
Mandana T Manzari   +2 more
exaly  

Home - About - Disclaimer - Privacy